Roche Glycart AG
https://www.roche.ch/en/sites/schlieren
8952 Schlieren, Wagistrasse 10
+41 43 215 10 00
The mission of the Roche Innovation Center Zurich (RICZ) is to be a leader in developing new generations of engineered antibody products with increased efficacy that address unmet clinical needs. The RICZ site is also the Center of Excellence in Cancer Immunotherapy within the Roche Group.
Roche Glycart AG
Wagistrasse 10
8952 Schlieren
2 Ergebnisse für "nice" unter Roche Glycart AG
Elecsys® CA 125 II
... . Version 1.2016 NICE (National Institute for Health and Clinical Exellence) Clinical Guideline: Ovarian ... Cancer: The Recognition and Initial Management of Ovarian Cancer, issued April 2011. NICE Clinical ... Cancer Including Fallopian Tube Cancer and Primary Periotoneal Cancer. Version 1.2016 NICE (National ... Management of Ovarian Cancer, issued April 2011. NICE Clinical Guideline 122. Ledermann J.A. et al. (2013 ...
Elecsys® CA 125 II
... . Version 1.2016 NICE (National Institute for Health and Clinical Exellence) Clinical Guideline: Ovarian ... Cancer: The Recognition and Initial Management of Ovarian Cancer, z dubna 2011. NICE Clinical Guideline ... Including Fallopian Tube Cancer and Primary Periotoneal Cancer. Version 1.2016 NICE (National Institute for ... of Ovarian Cancer, z dubna 2011. NICE Clinical Guideline 122. Ledermann J.A. et al. (2013) Annals of ...
Somagenetix
https://www.wysszurich.ch/projects/somagenetix
8952 Schlieren, Wagistrasse 23
Gene therapy solutions for patients with severe inherited diseases.
Somagenetix
Wagistrasse 23
8952 Schlieren
1 Ergebnisse für "nice" unter Somagenetix
Dunkelfeldbefragung im Bereich "Jugend und Gewalt" - Machbarkeitsstudie
Dunkelfeldbefragung im Bereich "Jugend und Gewalt" - Machbarkeitsstudie, https://www.ius.uzh.ch/dam/jcr:00000000-5624-ccd2-ffff-ffff9dd8c25c/Manzoni_et_al_2012.pdf, Dunkelfeldbefragung im Bereich ...
